Abstract |
This study was conducted to estimate the scattered thyroid dose and relevant second cancer risk from radiotherapy for extracranial tumours during childhood. Anteroposeterior and posteronaterior field irradiations employed during the treatment of Hodgkin's disease, neuroblastoma and Wilms' tumour were simulated on two humanoid phantoms representing 5- and 10-y-old patients. Measurements were performed using thermoluminescent dosemeters. Practical thyroid lead shields with thicknesses of 2-10 mm were placed in the phantoms' neck region. The lifetime risk for cancer induction was assessed using sex- and age-specific risk factors. Thyroid dose per monitor unit varied from 28.1 to 492.4 μGy by the primary irradiation site and patient's age. The 10-mm-thick lead shield led to a dose reduction up to 28.9 %. For typical prescribed tumour doses, the total risks for thyroid cancer development after radiotherapy of 5- and 10-y-old male patients were 0.05-0.99 and 0.03-0.48 %, respectively. The corresponding risks for females increased to 0.29-5.51 and 0.17-2.94 %.
|
Authors | Michalis Mazonakis, Kalliopi Kourinou, Efrossini Lyraraki, Haralambos Varveris, John Damilakis |
Journal | Radiation protection dosimetry
(Radiat Prot Dosimetry)
Vol. 152
Issue 4
Pg. 317-22
(Dec 2012)
ISSN: 1742-3406 [Electronic] England |
PMID | 22504308
(Publication Type: Journal Article)
|
Topics |
- Adolescent
- Brain Neoplasms
(epidemiology, radiotherapy)
- Child
- Comorbidity
- Female
- Humans
- Incidence
- Male
- Neoplasms, Radiation-Induced
(epidemiology)
- Organs at Risk
(radiation effects)
- Radiation Dosage
- Radiometry
(statistics & numerical data)
- Radiotherapy, Conformal
(statistics & numerical data)
- Risk Assessment
(methods)
- Scattering, Radiation
- Thyroid Gland
(radiation effects)
- Thyroid Neoplasms
(epidemiology)
|